Sterling Pharma Solutions
Kevin Cook has a diverse work experience spanning over three decades. Kevin started their career in 1987 as a Senior Plant Manager at Robinson Brothers Ltd and later worked as a Plant Manager at Boots Pharmaceuticals. In 1993, they joined ChiRex Ltd, where they served as the Head of Manufacturing and later as the Company Supply Chain Manager. In 2001, Cook became an Operations Director at Rhodia Pharma Solutions Ltd and continued in this role until 2006, when they became the Operations Director at Shasun Pharma Solutions. Cook then served as the President of Shasun from 2008 to 2011. Subsequently, they joined Aesica as the Managing Director of their API Business Unit until 2013. Currently, Cook holds the position of CEO at Sterling Pharma Solutions, a role they have been in since September 2016.
Kevin Cook received their Bachelor's degree in Chemistry from Newcastle University, where they studied from 1984 to 1987. Kevin furthered their education at the same university and obtained a Master of Business Administration (MBA) degree from 1989 to 1992.
This person is not in any offices
Sterling Pharma Solutions
1 followers
Sterling Pharma Solutions has over 50 years' experience serving the global pharmaceutical industry. Our facilities are located in Cramlington and Newcastle Biosphere, UK; Deeside, Wales; Cork, Ireland, as well as North Carolina and Wisconsin in the US. Our state-of-the-art facilities, proprietary technologies and experienced people are among the best in the industry. We have a proven track record in the supply of chemistry and analytical services across the entire product lifecycle, from grams to tonnes, from pre-clinical to commercial supply. Our world-class safety and quality standards are globally recognised and demonstrated through successful MHRA and FDA inspections and CIA Gold Awards for Safety the last three consecutive years. We pride ourselves on our customer focus and service approach, offering flexible, tailored solutions to our customers. In addition, our North Carolina and Newcastle Biosphere facilities offer expert chemistry solutions for small volume batches or products in the early stages of clinical trials. Our Deeside, Wales facility provide bioconjugation development services and specialised in antibody drug conjugation (ADC) research and development. Find out more: www.sterlingpharmasolutions.com/sterling-facilities